Novel N-benzenesulfonyl sophocarpinol derivatives as coxsackie B virus inhibitors

ACS Med Chem Lett. 2015 Jan 7;6(2):183-6. doi: 10.1021/ml500525s. eCollection 2015 Feb 12.

Abstract

Novel N-benzenesulfonyl sophocarpinic acid/ester and sophocarpinol derivatives were synthesized and evaluated for their antienteroviral activities against coxsackievirus type B3 (CVB3) from sophocarpine (1), a natural medicine isolated from Chinese herb. Structure-activity relationship (SAR) analysis revealed that the double bond and its geometrical configuration and position at the C-11 attachment did not greatly affect the potency. Among these derivatives, sophocarpinol 24d exerted the promising activities against not only CVB3 but also CVB1, CVB2, CVB5, and CVB6 with IC50 ranging from 0.62 to 3.63 μM (SI from 46 to 275), indicating a broad-spectrum antienteroviral characteristic. The SAR results provided the powerful information for further strategic optimization and development of a novel scaffold of broad-spectrum antiviral candidates against enteroviruses.

Keywords: Sophocarpine; coxsakievirus type B3; enteroviruse; sophocarpinol; structure−activity relationship.